img

Global Pemetrexed Disodium for Injection Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Pemetrexed Disodium for Injection Market Research Report 2024

According to Mr Accuracy reports’s new survey, global Pemetrexed Disodium for Injection market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pemetrexed Disodium for Injection market research.
Key manufacturers engaged in the Pemetrexed Disodium for Injection industry include Lilly, Amneal Pharmaceuticals, APOTEX, Fresenius Kabi, Sandoz, Baxter, Biocon, Waverley Pharma and Accord Healthcare, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Pemetrexed Disodium for Injection were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Pemetrexed Disodium for Injection market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pemetrexed Disodium for Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Lilly
Amneal Pharmaceuticals
APOTEX
Fresenius Kabi
Sandoz
Baxter
Biocon
Waverley Pharma
Accord Healthcare
Pfizer (Hospira)
Dr. Reddy's Laboratories
Nang Kuang Pharmaceutical
Eugia Pharma
Zydus Lifesciences
Jiangsu Hansoh Pharmaceutical
Qilu Pharmaceutical
Sichuan Huiyu Pharmaceutical
Kelun Pharmaceutical
Yangtze River Pharmaceutical Group
Jiangsu Aosaikang Pharmaceutical
Zhendong Group
Lianyungang Jaripharm Pharmaceutical
Jiangsu Simcere Pharmaceutical
Suzhou Erye Pharmaceutical
Shanghai Chemo Wanbang Biopharma
Hainan Jinrui Pharmaceutical
Dezhou Deyao Pharmaceutical
Nanjing Pharmaceutical Factory
Beijing Xiehe Pharmaceutical
Suzhou Thery Pharmaceutical
Segment by Type
100mg/Pcs
500mg/Pcs

Segment by Application


Hospitals
Clinics
Others

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Pemetrexed Disodium for Injection report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Pemetrexed Disodium for Injection Market Overview
1.1 Product Overview and Scope of Pemetrexed Disodium for Injection
1.2 Pemetrexed Disodium for Injection Segment by Type
1.2.1 Global Pemetrexed Disodium for Injection Market Value Comparison by Type (2024-2034)
1.2.2 100mg/Pcs
1.2.3 500mg/Pcs
1.3 Pemetrexed Disodium for Injection Segment by Application
1.3.1 Global Pemetrexed Disodium for Injection Market Value by Application: (2024-2034)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Pemetrexed Disodium for Injection Market Size Estimates and Forecasts
1.4.1 Global Pemetrexed Disodium for Injection Revenue 2024-2034
1.4.2 Global Pemetrexed Disodium for Injection Sales 2024-2034
1.4.3 Global Pemetrexed Disodium for Injection Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Pemetrexed Disodium for Injection Market Competition by Manufacturers
2.1 Global Pemetrexed Disodium for Injection Sales Market Share by Manufacturers (2024-2024)
2.2 Global Pemetrexed Disodium for Injection Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Pemetrexed Disodium for Injection Average Price by Manufacturers (2024-2024)
2.4 Global Pemetrexed Disodium for Injection Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Pemetrexed Disodium for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pemetrexed Disodium for Injection, Product Type & Application
2.7 Pemetrexed Disodium for Injection Market Competitive Situation and Trends
2.7.1 Pemetrexed Disodium for Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pemetrexed Disodium for Injection Players Market Share by Revenue
2.7.3 Global Pemetrexed Disodium for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pemetrexed Disodium for Injection Retrospective Market Scenario by Region
3.1 Global Pemetrexed Disodium for Injection Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Pemetrexed Disodium for Injection Global Pemetrexed Disodium for Injection Sales by Region: 2024-2034
3.2.1 Global Pemetrexed Disodium for Injection Sales by Region: 2024-2024
3.2.2 Global Pemetrexed Disodium for Injection Sales by Region: 2024-2034
3.3 Global Pemetrexed Disodium for Injection Global Pemetrexed Disodium for Injection Revenue by Region: 2024-2034
3.3.1 Global Pemetrexed Disodium for Injection Revenue by Region: 2024-2024
3.3.2 Global Pemetrexed Disodium for Injection Revenue by Region: 2024-2034
3.4 North America Pemetrexed Disodium for Injection Market Facts & Figures by Country
3.4.1 North America Pemetrexed Disodium for Injection Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Pemetrexed Disodium for Injection Sales by Country (2024-2034)
3.4.3 North America Pemetrexed Disodium for Injection Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pemetrexed Disodium for Injection Market Facts & Figures by Country
3.5.1 Europe Pemetrexed Disodium for Injection Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Pemetrexed Disodium for Injection Sales by Country (2024-2034)
3.5.3 Europe Pemetrexed Disodium for Injection Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pemetrexed Disodium for Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Pemetrexed Disodium for Injection Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Pemetrexed Disodium for Injection Sales by Country (2024-2034)
3.6.3 Asia Pacific Pemetrexed Disodium for Injection Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pemetrexed Disodium for Injection Market Facts & Figures by Country
3.7.1 Latin America Pemetrexed Disodium for Injection Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Pemetrexed Disodium for Injection Sales by Country (2024-2034)
3.7.3 Latin America Pemetrexed Disodium for Injection Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pemetrexed Disodium for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Pemetrexed Disodium for Injection Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Pemetrexed Disodium for Injection Sales by Country (2024-2034)
3.8.3 Middle East and Africa Pemetrexed Disodium for Injection Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pemetrexed Disodium for Injection Sales by Type (2024-2034)
4.1.1 Global Pemetrexed Disodium for Injection Sales by Type (2024-2024)
4.1.2 Global Pemetrexed Disodium for Injection Sales by Type (2024-2034)
4.1.3 Global Pemetrexed Disodium for Injection Sales Market Share by Type (2024-2034)
4.2 Global Pemetrexed Disodium for Injection Revenue by Type (2024-2034)
4.2.1 Global Pemetrexed Disodium for Injection Revenue by Type (2024-2024)
4.2.2 Global Pemetrexed Disodium for Injection Revenue by Type (2024-2034)
4.2.3 Global Pemetrexed Disodium for Injection Revenue Market Share by Type (2024-2034)
4.3 Global Pemetrexed Disodium for Injection Price by Type (2024-2034)
5 Segment by Application
5.1 Global Pemetrexed Disodium for Injection Sales by Application (2024-2034)
5.1.1 Global Pemetrexed Disodium for Injection Sales by Application (2024-2024)
5.1.2 Global Pemetrexed Disodium for Injection Sales by Application (2024-2034)
5.1.3 Global Pemetrexed Disodium for Injection Sales Market Share by Application (2024-2034)
5.2 Global Pemetrexed Disodium for Injection Revenue by Application (2024-2034)
5.2.1 Global Pemetrexed Disodium for Injection Revenue by Application (2024-2024)
5.2.2 Global Pemetrexed Disodium for Injection Revenue by Application (2024-2034)
5.2.3 Global Pemetrexed Disodium for Injection Revenue Market Share by Application (2024-2034)
5.3 Global Pemetrexed Disodium for Injection Price by Application (2024-2034)
6 Key Companies Profiled
6.1 Lilly
6.1.1 Lilly Corporation Information
6.1.2 Lilly Description and Business Overview
6.1.3 Lilly Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2024-2024)
6.1.4 Lilly Pemetrexed Disodium for Injection Product Portfolio
6.1.5 Lilly Recent Developments/Updates
6.2 Amneal Pharmaceuticals
6.2.1 Amneal Pharmaceuticals Corporation Information
6.2.2 Amneal Pharmaceuticals Description and Business Overview
6.2.3 Amneal Pharmaceuticals Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Amneal Pharmaceuticals Pemetrexed Disodium for Injection Product Portfolio
6.2.5 Amneal Pharmaceuticals Recent Developments/Updates
6.3 APOTEX
6.3.1 APOTEX Corporation Information
6.3.2 APOTEX Description and Business Overview
6.3.3 APOTEX Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2024-2024)
6.3.4 APOTEX Pemetrexed Disodium for Injection Product Portfolio
6.3.5 APOTEX Recent Developments/Updates
6.4 Fresenius Kabi
6.4.1 Fresenius Kabi Corporation Information
6.4.2 Fresenius Kabi Description and Business Overview
6.4.3 Fresenius Kabi Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Fresenius Kabi Pemetrexed Disodium for Injection Product Portfolio
6.4.5 Fresenius Kabi Recent Developments/Updates
6.5 Sandoz
6.5.1 Sandoz Corporation Information
6.5.2 Sandoz Description and Business Overview
6.5.3 Sandoz Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2024-2024)
6.5.4 Sandoz Pemetrexed Disodium for Injection Product Portfolio
6.5.5 Sandoz Recent Developments/Updates
6.6 Baxter
6.6.1 Baxter Corporation Information
6.6.2 Baxter Description and Business Overview
6.6.3 Baxter Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2024-2024)
6.6.4 Baxter Pemetrexed Disodium for Injection Product Portfolio
6.6.5 Baxter Recent Developments/Updates
6.7 Biocon
6.6.1 Biocon Corporation Information
6.6.2 Biocon Description and Business Overview
6.6.3 Biocon Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Biocon Pemetrexed Disodium for Injection Product Portfolio
6.7.5 Biocon Recent Developments/Updates
6.8 Waverley Pharma
6.8.1 Waverley Pharma Corporation Information
6.8.2 Waverley Pharma Description and Business Overview
6.8.3 Waverley Pharma Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2024-2024)
6.8.4 Waverley Pharma Pemetrexed Disodium for Injection Product Portfolio
6.8.5 Waverley Pharma Recent Developments/Updates
6.9 Accord Healthcare
6.9.1 Accord Healthcare Corporation Information
6.9.2 Accord Healthcare Description and Business Overview
6.9.3 Accord Healthcare Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2024-2024)
6.9.4 Accord Healthcare Pemetrexed Disodium for Injection Product Portfolio
6.9.5 Accord Healthcare Recent Developments/Updates
6.10 Pfizer (Hospira)
6.10.1 Pfizer (Hospira) Corporation Information
6.10.2 Pfizer (Hospira) Description and Business Overview
6.10.3 Pfizer (Hospira) Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2024-2024)
6.10.4 Pfizer (Hospira) Pemetrexed Disodium for Injection Product Portfolio
6.10.5 Pfizer (Hospira) Recent Developments/Updates
6.11 Dr. Reddy's Laboratories
6.11.1 Dr. Reddy's Laboratories Corporation Information
6.11.2 Dr. Reddy's Laboratories Pemetrexed Disodium for Injection Description and Business Overview
6.11.3 Dr. Reddy's Laboratories Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2024-2024)
6.11.4 Dr. Reddy's Laboratories Pemetrexed Disodium for Injection Product Portfolio
6.11.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.12 Nang Kuang Pharmaceutical
6.12.1 Nang Kuang Pharmaceutical Corporation Information
6.12.2 Nang Kuang Pharmaceutical Pemetrexed Disodium for Injection Description and Business Overview
6.12.3 Nang Kuang Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2024-2024)
6.12.4 Nang Kuang Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
6.12.5 Nang Kuang Pharmaceutical Recent Developments/Updates
6.13 Eugia Pharma
6.13.1 Eugia Pharma Corporation Information
6.13.2 Eugia Pharma Pemetrexed Disodium for Injection Description and Business Overview
6.13.3 Eugia Pharma Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2024-2024)
6.13.4 Eugia Pharma Pemetrexed Disodium for Injection Product Portfolio
6.13.5 Eugia Pharma Recent Developments/Updates
6.14 Zydus Lifesciences
6.14.1 Zydus Lifesciences Corporation Information
6.14.2 Zydus Lifesciences Pemetrexed Disodium for Injection Description and Business Overview
6.14.3 Zydus Lifesciences Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2024-2024)
6.14.4 Zydus Lifesciences Pemetrexed Disodium for Injection Product Portfolio
6.14.5 Zydus Lifesciences Recent Developments/Updates
6.15 Jiangsu Hansoh Pharmaceutical
6.15.1 Jiangsu Hansoh Pharmaceutical Corporation Information
6.15.2 Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium for Injection Description and Business Overview
6.15.3 Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2024-2024)
6.15.4 Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
6.15.5 Jiangsu Hansoh Pharmaceutical Recent Developments/Updates
6.16 Qilu Pharmaceutical
6.16.1 Qilu Pharmaceutical Corporation Information
6.16.2 Qilu Pharmaceutical Pemetrexed Disodium for Injection Description and Business Overview
6.16.3 Qilu Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2024-2024)
6.16.4 Qilu Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
6.16.5 Qilu Pharmaceutical Recent Developments/Updates
6.17 Sichuan Huiyu Pharmaceutical
6.17.1 Sichuan Huiyu Pharmaceutical Corporation Information
6.17.2 Sichuan Huiyu Pharmaceutical Pemetrexed Disodium for Injection Description and Business Overview
6.17.3 Sichuan Huiyu Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2024-2024)
6.17.4 Sichuan Huiyu Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
6.17.5 Sichuan Huiyu Pharmaceutical Recent Developments/Updates
6.18 Kelun Pharmaceutical
6.18.1 Kelun Pharmaceutical Corporation Information
6.18.2 Kelun Pharmaceutical Pemetrexed Disodium for Injection Description and Business Overview
6.18.3 Kelun Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2024-2024)
6.18.4 Kelun Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
6.18.5 Kelun Pharmaceutical Recent Developments/Updates
6.19 Yangtze River Pharmaceutical Group
6.19.1 Yangtze River Pharmaceutical Group Corporation Information
6.19.2 Yangtze River Pharmaceutical Group Pemetrexed Disodium for Injection Description and Business Overview
6.19.3 Yangtze River Pharmaceutical Group Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2024-2024)
6.19.4 Yangtze River Pharmaceutical Group Pemetrexed Disodium for Injection Product Portfolio
6.19.5 Yangtze River Pharmaceutical Group Recent Developments/Updates
6.20 Jiangsu Aosaikang Pharmaceutical
6.20.1 Jiangsu Aosaikang Pharmaceutical Corporation Information
6.20.2 Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium for Injection Description and Business Overview
6.20.3 Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2024-2024)
6.20.4 Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
6.20.5 Jiangsu Aosaikang Pharmaceutical Recent Developments/Updates
6.21 Zhendong Group
6.21.1 Zhendong Group Corporation Information
6.21.2 Zhendong Group Pemetrexed Disodium for Injection Description and Business Overview
6.21.3 Zhendong Group Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2024-2024)
6.21.4 Zhendong Group Pemetrexed Disodium for Injection Product Portfolio
6.21.5 Zhendong Group Recent Developments/Updates
6.22 Lianyungang Jaripharm Pharmaceutical
6.22.1 Lianyungang Jaripharm Pharmaceutical Corporation Information
6.22.2 Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium for Injection Description and Business Overview
6.22.3 Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2024-2024)
6.22.4 Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
6.22.5 Lianyungang Jaripharm Pharmaceutical Recent Developments/Updates
6.23 Jiangsu Simcere Pharmaceutical
6.23.1 Jiangsu Simcere Pharmaceutical Corporation Information
6.23.2 Jiangsu Simcere Pharmaceutical Pemetrexed Disodium for Injection Description and Business Overview
6.23.3 Jiangsu Simcere Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2024-2024)
6.23.4 Jiangsu Simcere Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
6.23.5 Jiangsu Simcere Pharmaceutical Recent Developments/Updates
6.24 Suzhou Erye Pharmaceutical
6.24.1 Suzhou Erye Pharmaceutical Corporation Information
6.24.2 Suzhou Erye Pharmaceutical Pemetrexed Disodium for Injection Description and Business Overview
6.24.3 Suzhou Erye Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2024-2024)
6.24.4 Suzhou Erye Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
6.24.5 Suzhou Erye Pharmaceutical Recent Developments/Updates
6.25 Shanghai Chemo Wanbang Biopharma
6.25.1 Shanghai Chemo Wanbang Biopharma Corporation Information
6.25.2 Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium for Injection Description and Business Overview
6.25.3 Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2024-2024)
6.25.4 Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium for Injection Product Portfolio
6.25.5 Shanghai Chemo Wanbang Biopharma Recent Developments/Updates
6.26 Hainan Jinrui Pharmaceutical
6.26.1 Hainan Jinrui Pharmaceutical Corporation Information
6.26.2 Hainan Jinrui Pharmaceutical Pemetrexed Disodium for Injection Description and Business Overview
6.26.3 Hainan Jinrui Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2024-2024)
6.26.4 Hainan Jinrui Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
6.26.5 Hainan Jinrui Pharmaceutical Recent Developments/Updates
6.27 Dezhou Deyao Pharmaceutical
6.27.1 Dezhou Deyao Pharmaceutical Corporation Information
6.27.2 Dezhou Deyao Pharmaceutical Pemetrexed Disodium for Injection Description and Business Overview
6.27.3 Dezhou Deyao Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2024-2024)
6.27.4 Dezhou Deyao Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
6.27.5 Dezhou Deyao Pharmaceutical Recent Developments/Updates
6.28 Nanjing Pharmaceutical Factory
6.28.1 Nanjing Pharmaceutical Factory Corporation Information
6.28.2 Nanjing Pharmaceutical Factory Pemetrexed Disodium for Injection Description and Business Overview
6.28.3 Nanjing Pharmaceutical Factory Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2024-2024)
6.28.4 Nanjing Pharmaceutical Factory Pemetrexed Disodium for Injection Product Portfolio
6.28.5 Nanjing Pharmaceutical Factory Recent Developments/Updates
6.29 Beijing Xiehe Pharmaceutical
6.29.1 Beijing Xiehe Pharmaceutical Corporation Information
6.29.2 Beijing Xiehe Pharmaceutical Pemetrexed Disodium for Injection Description and Business Overview
6.29.3 Beijing Xiehe Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2024-2024)
6.29.4 Beijing Xiehe Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
6.29.5 Beijing Xiehe Pharmaceutical Recent Developments/Updates
6.30 Suzhou Thery Pharmaceutical
6.30.1 Suzhou Thery Pharmaceutical Corporation Information
6.30.2 Suzhou Thery Pharmaceutical Pemetrexed Disodium for Injection Description and Business Overview
6.30.3 Suzhou Thery Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2024-2024)
6.30.4 Suzhou Thery Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
6.30.5 Suzhou Thery Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pemetrexed Disodium for Injection Industry Chain Analysis
7.2 Pemetrexed Disodium for Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pemetrexed Disodium for Injection Production Mode & Process
7.4 Pemetrexed Disodium for Injection Sales and Marketing
7.4.1 Pemetrexed Disodium for Injection Sales Channels
7.4.2 Pemetrexed Disodium for Injection Distributors
7.5 Pemetrexed Disodium for Injection Customers
8 Pemetrexed Disodium for Injection Market Dynamics
8.1 Pemetrexed Disodium for Injection Industry Trends
8.2 Pemetrexed Disodium for Injection Market Drivers
8.3 Pemetrexed Disodium for Injection Market Challenges
8.4 Pemetrexed Disodium for Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Pemetrexed Disodium for Injection Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Pemetrexed Disodium for Injection Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Pemetrexed Disodium for Injection Market Competitive Situation by Manufacturers in 2022
Table 4. Global Pemetrexed Disodium for Injection Sales (K Units) of Key Manufacturers (2024-2024)
Table 5. Global Pemetrexed Disodium for Injection Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Pemetrexed Disodium for Injection Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Pemetrexed Disodium for Injection Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Pemetrexed Disodium for Injection Average Price (US$/Unit) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Pemetrexed Disodium for Injection, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Pemetrexed Disodium for Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pemetrexed Disodium for Injection, Product Type & Application
Table 12. Global Key Manufacturers of Pemetrexed Disodium for Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pemetrexed Disodium for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pemetrexed Disodium for Injection as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pemetrexed Disodium for Injection Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Pemetrexed Disodium for Injection Sales by Region (2024-2024) & (K Units)
Table 18. Global Pemetrexed Disodium for Injection Sales Market Share by Region (2024-2024)
Table 19. Global Pemetrexed Disodium for Injection Sales by Region (2024-2034) & (K Units)
Table 20. Global Pemetrexed Disodium for Injection Sales Market Share by Region (2024-2034)
Table 21. Global Pemetrexed Disodium for Injection Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Pemetrexed Disodium for Injection Revenue Market Share by Region (2024-2024)
Table 23. Global Pemetrexed Disodium for Injection Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Pemetrexed Disodium for Injection Revenue Market Share by Region (2024-2034)
Table 25. North America Pemetrexed Disodium for Injection Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Pemetrexed Disodium for Injection Sales by Country (2024-2024) & (K Units)
Table 27. North America Pemetrexed Disodium for Injection Sales by Country (2024-2034) & (K Units)
Table 28. North America Pemetrexed Disodium for Injection Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Pemetrexed Disodium for Injection Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Pemetrexed Disodium for Injection Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Pemetrexed Disodium for Injection Sales by Country (2024-2024) & (K Units)
Table 32. Europe Pemetrexed Disodium for Injection Sales by Country (2024-2034) & (K Units)
Table 33. Europe Pemetrexed Disodium for Injection Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Pemetrexed Disodium for Injection Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Pemetrexed Disodium for Injection Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Pemetrexed Disodium for Injection Sales by Region (2024-2024) & (K Units)
Table 37. Asia Pacific Pemetrexed Disodium for Injection Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Pemetrexed Disodium for Injection Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Pemetrexed Disodium for Injection Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Pemetrexed Disodium for Injection Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Pemetrexed Disodium for Injection Sales by Country (2024-2024) & (K Units)
Table 42. Latin America Pemetrexed Disodium for Injection Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Pemetrexed Disodium for Injection Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Pemetrexed Disodium for Injection Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Pemetrexed Disodium for Injection Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Pemetrexed Disodium for Injection Sales by Country (2024-2024) & (K Units)
Table 47. Middle East & Africa Pemetrexed Disodium for Injection Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Pemetrexed Disodium for Injection Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Pemetrexed Disodium for Injection Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Pemetrexed Disodium for Injection Sales (K Units) by Type (2024-2024)
Table 51. Global Pemetrexed Disodium for Injection Sales (K Units) by Type (2024-2034)
Table 52. Global Pemetrexed Disodium for Injection Sales Market Share by Type (2024-2024)
Table 53. Global Pemetrexed Disodium for Injection Sales Market Share by Type (2024-2034)
Table 54. Global Pemetrexed Disodium for Injection Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Pemetrexed Disodium for Injection Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Pemetrexed Disodium for Injection Revenue Market Share by Type (2024-2024)
Table 57. Global Pemetrexed Disodium for Injection Revenue Market Share by Type (2024-2034)
Table 58. Global Pemetrexed Disodium for Injection Price (US$/Unit) by Type (2024-2024)
Table 59. Global Pemetrexed Disodium for Injection Price (US$/Unit) by Type (2024-2034)
Table 60. Global Pemetrexed Disodium for Injection Sales (K Units) by Application (2024-2024)
Table 61. Global Pemetrexed Disodium for Injection Sales (K Units) by Application (2024-2034)
Table 62. Global Pemetrexed Disodium for Injection Sales Market Share by Application (2024-2024)
Table 63. Global Pemetrexed Disodium for Injection Sales Market Share by Application (2024-2034)
Table 64. Global Pemetrexed Disodium for Injection Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Pemetrexed Disodium for Injection Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Pemetrexed Disodium for Injection Revenue Market Share by Application (2024-2024)
Table 67. Global Pemetrexed Disodium for Injection Revenue Market Share by Application (2024-2034)
Table 68. Global Pemetrexed Disodium for Injection Price (US$/Unit) by Application (2024-2024)
Table 69. Global Pemetrexed Disodium for Injection Price (US$/Unit) by Application (2024-2034)
Table 70. Lilly Corporation Information
Table 71. Lilly Description and Business Overview
Table 72. Lilly Pemetrexed Disodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 73. Lilly Pemetrexed Disodium for Injection Product
Table 74. Lilly Recent Developments/Updates
Table 75. Amneal Pharmaceuticals Corporation Information
Table 76. Amneal Pharmaceuticals Description and Business Overview
Table 77. Amneal Pharmaceuticals Pemetrexed Disodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 78. Amneal Pharmaceuticals Pemetrexed Disodium for Injection Product
Table 79. Amneal Pharmaceuticals Recent Developments/Updates
Table 80. APOTEX Corporation Information
Table 81. APOTEX Description and Business Overview
Table 82. APOTEX Pemetrexed Disodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 83. APOTEX Pemetrexed Disodium for Injection Product
Table 84. APOTEX Recent Developments/Updates
Table 85. Fresenius Kabi Corporation Information
Table 86. Fresenius Kabi Description and Business Overview
Table 87. Fresenius Kabi Pemetrexed Disodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 88. Fresenius Kabi Pemetrexed Disodium for Injection Product
Table 89. Fresenius Kabi Recent Developments/Updates
Table 90. Sandoz Corporation Information
Table 91. Sandoz Description and Business Overview
Table 92. Sandoz Pemetrexed Disodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 93. Sandoz Pemetrexed Disodium for Injection Product
Table 94. Sandoz Recent Developments/Updates
Table 95. Baxter Corporation Information
Table 96. Baxter Description and Business Overview
Table 97. Baxter Pemetrexed Disodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 98. Baxter Pemetrexed Disodium for Injection Product
Table 99. Baxter Recent Developments/Updates
Table 100. Biocon Corporation Information
Table 101. Biocon Description and Business Overview
Table 102. Biocon Pemetrexed Disodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 103. Biocon Pemetrexed Disodium for Injection Product
Table 104. Biocon Recent Developments/Updates
Table 105. Waverley Pharma Corporation Information
Table 106. Waverley Pharma Description and Business Overview
Table 107. Waverley Pharma Pemetrexed Disodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 108. Waverley Pharma Pemetrexed Disodium for Injection Product
Table 109. Waverley Pharma Recent Developments/Updates
Table 110. Accord Healthcare Corporation Information
Table 111. Accord Healthcare Description and Business Overview
Table 112. Accord Healthcare Pemetrexed Disodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 113. Accord Healthcare Pemetrexed Disodium for Injection Product
Table 114. Accord Healthcare Recent Developments/Updates
Table 115. Pfizer (Hospira) Corporation Information
Table 116. Pfizer (Hospira) Description and Business Overview
Table 117. Pfizer (Hospira) Pemetrexed Disodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 118. Pfizer (Hospira) Pemetrexed Disodium for Injection Product
Table 119. Pfizer (Hospira) Recent Developments/Updates
Table 120. Dr. Reddy's Laboratories Corporation Information
Table 121. Dr. Reddy's Laboratories Description and Business Overview
Table 122. Dr. Reddy's Laboratories Pemetrexed Disodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 123. Dr. Reddy's Laboratories Pemetrexed Disodium for Injection Product
Table 124. Dr. Reddy's Laboratories Recent Developments/Updates
Table 125. Nang Kuang Pharmaceutical Corporation Information
Table 126. Nang Kuang Pharmaceutical Description and Business Overview
Table 127. Nang Kuang Pharmaceutical Pemetrexed Disodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 128. Nang Kuang Pharmaceutical Pemetrexed Disodium for Injection Product
Table 129. Nang Kuang Pharmaceutical Recent Developments/Updates
Table 130. Eugia Pharma Corporation Information
Table 131. Eugia Pharma Description and Business Overview
Table 132. Eugia Pharma Pemetrexed Disodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 133. Eugia Pharma Pemetrexed Disodium for Injection Product
Table 134. Eugia Pharma Recent Developments/Updates
Table 135. Zydus Lifesciences Corporation Information
Table 136. Zydus Lifesciences Description and Business Overview
Table 137. Zydus Lifesciences Pemetrexed Disodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 138. Zydus Lifesciences Pemetrexed Disodium for Injection Product
Table 139. Zydus Lifesciences Recent Developments/Updates
Table 140. Jiangsu Hansoh Pharmaceutical Corporation Information
Table 141. Jiangsu Hansoh Pharmaceutical Description and Business Overview
Table 142. Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 143. Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium for Injection Product
Table 144. Jiangsu Hansoh Pharmaceutical Recent Developments/Updates
Table 145. Qilu Pharmaceutical Corporation Information
Table 146. Qilu Pharmaceutical Description and Business Overview
Table 147. Qilu Pharmaceutical Pemetrexed Disodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 148. Qilu Pharmaceutical Pemetrexed Disodium for Injection Product
Table 149. Qilu Pharmaceutical Recent Developments/Updates
Table 150. Sichuan Huiyu Pharmaceutical Corporation Information
Table 151. Sichuan Huiyu Pharmaceutical Description and Business Overview
Table 152. Sichuan Huiyu Pharmaceutical Pemetrexed Disodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 153. Sichuan Huiyu Pharmaceutical Pemetrexed Disodium for Injection Product
Table 154. Sichuan Huiyu Pharmaceutical Recent Developments/Updates
Table 155. Kelun Pharmaceutical Corporation Information
Table 156. Kelun Pharmaceutical Description and Business Overview
Table 157. Kelun Pharmaceutical Pemetrexed Disodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 158. Kelun Pharmaceutical Pemetrexed Disodium for Injection Product
Table 159. Kelun Pharmaceutical Recent Developments/Updates
Table 160. Yangtze River Pharmaceutical Group Corporation Information
Table 161. Yangtze River Pharmaceutical Group Description and Business Overview
Table 162. Yangtze River Pharmaceutical Group Pemetrexed Disodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 163. Yangtze River Pharmaceutical Group Pemetrexed Disodium for Injection Product
Table 164. Yangtze River Pharmaceutical Group Recent Developments/Updates
Table 165. Jiangsu Aosaikang Pharmaceutical Corporation Information
Table 166. Jiangsu Aosaikang Pharmaceutical Description and Business Overview
Table 167. Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 168. Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium for Injection Product
Table 169. Jiangsu Aosaikang Pharmaceutical Recent Developments/Updates
Table 170. Zhendong Group Corporation Information
Table 171. Zhendong Group Description and Business Overview
Table 172. Zhendong Group Pemetrexed Disodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 173. Zhendong Group Pemetrexed Disodium for Injection Product
Table 174. Zhendong Group Recent Developments/Updates
Table 175. Lianyungang Jaripharm Pharmaceutical Corporation Information
Table 176. Lianyungang Jaripharm Pharmaceutical Description and Business Overview
Table 177. Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 178. Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium for Injection Product
Table 179. Lianyungang Jaripharm Pharmaceutical Recent Developments/Updates
Table 180. Jiangsu Simcere Pharmaceutical Corporation Information
Table 181. Jiangsu Simcere Pharmaceutical Description and Business Overview
Table 182. Jiangsu Simcere Pharmaceutical Pemetrexed Disodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 183. Jiangsu Simcere Pharmaceutical Pemetrexed Disodium for Injection Product
Table 184. Jiangsu Simcere Pharmaceutical Recent Developments/Updates
Table 185. Suzhou Erye Pharmaceutical Corporation Information
Table 186. Suzhou Erye Pharmaceutical Description and Business Overview
Table 187. Suzhou Erye Pharmaceutical Pemetrexed Disodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 188. Suzhou Erye Pharmaceutical Pemetrexed Disodium for Injection Product
Table 189. Suzhou Erye Pharmaceutical Recent Developments/Updates
Table 190. Shanghai Chemo Wanbang Biopharma Corporation Information
Table 191. Shanghai Chemo Wanbang Biopharma Description and Business Overview
Table 192. Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 193. Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium for Injection Product
Table 194. Shanghai Chemo Wanbang Biopharma Recent Developments/Updates
Table 195. Hainan Jinrui Pharmaceutical Corporation Information
Table 196. Hainan Jinrui Pharmaceutical Description and Business Overview
Table 197. Hainan Jinrui Pharmaceutical Pemetrexed Disodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 198. Hainan Jinrui Pharmaceutical Pemetrexed Disodium for Injection Product
Table 199. Hainan Jinrui Pharmaceutical Recent Developments/Updates
Table 200. Dezhou Deyao Pharmaceutical Corporation Information
Table 201. Dezhou Deyao Pharmaceutical Description and Business Overview
Table 202. Dezhou Deyao Pharmaceutical Pemetrexed Disodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 203. Dezhou Deyao Pharmaceutical Pemetrexed Disodium for Injection Product
Table 204. Dezhou Deyao Pharmaceutical Recent Developments/Updates
Table 205. Nanjing Pharmaceutical Factory Corporation Information
Table 206. Nanjing Pharmaceutical Factory Description and Business Overview
Table 207. Nanjing Pharmaceutical Factory Pemetrexed Disodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 208. Nanjing Pharmaceutical Factory Pemetrexed Disodium for Injection Product
Table 209. Nanjing Pharmaceutical Factory Recent Developments/Updates
Table 210. Beijing Xiehe Pharmaceutical Corporation Information
Table 211. Beijing Xiehe Pharmaceutical Description and Business Overview
Table 212. Beijing Xiehe Pharmaceutical Pemetrexed Disodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 213. Beijing Xiehe Pharmaceutical Pemetrexed Disodium for Injection Product
Table 214. Beijing Xiehe Pharmaceutical Recent Developments/Updates
Table 215. Suzhou Thery Pharmaceutical Corporation Information
Table 216. Suzhou Thery Pharmaceutical Description and Business Overview
Table 217. Suzhou Thery Pharmaceutical Pemetrexed Disodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 218. Suzhou Thery Pharmaceutical Pemetrexed Disodium for Injection Product
Table 219. Suzhou Thery Pharmaceutical Recent Developments/Updates
Table 220. Key Raw Materials Lists
Table 221. Raw Materials Key Suppliers Lists
Table 222. Pemetrexed Disodium for Injection Distributors List
Table 223. Pemetrexed Disodium for Injection Customers List
Table 224. Pemetrexed Disodium for Injection Market Trends
Table 225. Pemetrexed Disodium for Injection Market Drivers
Table 226. Pemetrexed Disodium for Injection Market Challenges
Table 227. Pemetrexed Disodium for Injection Market Restraints
Table 228. Research Programs/Design for This Report
Table 229. Key Data Information from Secondary Sources
Table 230. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pemetrexed Disodium for Injection
Figure 2. Global Pemetrexed Disodium for Injection Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Pemetrexed Disodium for Injection Market Share by Type in 2022 & 2034
Figure 4. 100mg/Pcs Product Picture
Figure 5. 500mg/Pcs Product Picture
Figure 6. Global Pemetrexed Disodium for Injection Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Pemetrexed Disodium for Injection Market Share by Application in 2022 & 2034
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Others
Figure 11. Global Pemetrexed Disodium for Injection Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 12. Global Pemetrexed Disodium for Injection Market Size (2024-2034) & (US$ Million)
Figure 13. Global Pemetrexed Disodium for Injection Sales (2024-2034) & (K Units)
Figure 14. Global Pemetrexed Disodium for Injection Average Price (US$/Unit) & (2024-2034)
Figure 15. Pemetrexed Disodium for Injection Report Years Considered
Figure 16. Pemetrexed Disodium for Injection Sales Share by Manufacturers in 2022
Figure 17. Global Pemetrexed Disodium for Injection Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Pemetrexed Disodium for Injection Players: Market Share by Revenue in 2022
Figure 19. Pemetrexed Disodium for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 20. Global Pemetrexed Disodium for Injection Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 21. North America Pemetrexed Disodium for Injection Sales Market Share by Country (2024-2034)
Figure 22. North America Pemetrexed Disodium for Injection Revenue Market Share by Country (2024-2034)
Figure 23. United States Pemetrexed Disodium for Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 24. Canada Pemetrexed Disodium for Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 25. Europe Pemetrexed Disodium for Injection Sales Market Share by Country (2024-2034)
Figure 26. Europe Pemetrexed Disodium for Injection Revenue Market Share by Country (2024-2034)
Figure 27. Germany Pemetrexed Disodium for Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 28. France Pemetrexed Disodium for Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 29. U.K. Pemetrexed Disodium for Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 30. Italy Pemetrexed Disodium for Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. Russia Pemetrexed Disodium for Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 32. Asia Pacific Pemetrexed Disodium for Injection Sales Market Share by Region (2024-2034)
Figure 33. Asia Pacific Pemetrexed Disodium for Injection Revenue Market Share by Region (2024-2034)
Figure 34. China Pemetrexed Disodium for Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 35. Japan Pemetrexed Disodium for Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 36. South Korea Pemetrexed Disodium for Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 37. India Pemetrexed Disodium for Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. Australia Pemetrexed Disodium for Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. China Taiwan Pemetrexed Disodium for Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. Southeast Asia Pemetrexed Disodium for Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. Latin America Pemetrexed Disodium for Injection Sales Market Share by Country (2024-2034)
Figure 42. Latin America Pemetrexed Disodium for Injection Revenue Market Share by Country (2024-2034)
Figure 43. Mexico Pemetrexed Disodium for Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 44. Brazil Pemetrexed Disodium for Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 45. Argentina Pemetrexed Disodium for Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 46. Colombia Pemetrexed Disodium for Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 47. Middle East & Africa Pemetrexed Disodium for Injection Sales Market Share by Country (2024-2034)
Figure 48. Middle East & Africa Pemetrexed Disodium for Injection Revenue Market Share by Country (2024-2034)
Figure 49. Turkey Pemetrexed Disodium for Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 50. Saudi Arabia Pemetrexed Disodium for Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 51. UAE Pemetrexed Disodium for Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 52. Global Sales Market Share of Pemetrexed Disodium for Injection by Type (2024-2034)
Figure 53. Global Revenue Market Share of Pemetrexed Disodium for Injection by Type (2024-2034)
Figure 54. Global Pemetrexed Disodium for Injection Price (US$/Unit) by Type (2024-2034)
Figure 55. Global Sales Market Share of Pemetrexed Disodium for Injection by Application (2024-2034)
Figure 56. Global Revenue Market Share of Pemetrexed Disodium for Injection by Application (2024-2034)
Figure 57. Global Pemetrexed Disodium for Injection Price (US$/Unit) by Application (2024-2034)
Figure 58. Pemetrexed Disodium for Injection Value Chain
Figure 59. Pemetrexed Disodium for Injection Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed